Literature DB >> 8724002

Molecular cloning and characterization of tumor necrosis factor alpha (TNF-alpha) from the Australian common brushtail possum, Trichosurus vulpecula.

D N Wedlock1, F E Aldwell, B M Buddle.   

Abstract

Immune responses in the Australian common brushtail possum (Trichosurus vulpecula) and in particular the role of cytokines are poorly understood. We have undertaken to isolate cytokine genes using reverse transcriptase-polymerase chain reaction (RT-PCR) and in this study describe the molecular cloning of TNF-alpha. Primers were designed from consensus sequences at the N-terminus end of eutherian mammalian TNF-alpha and the possum cDNA, derived from spleen RNA, identified by RT-PCR. The complete cDNA encoding possum TNF-alpha was amplified from lymphocyte RNA by 5' and 3' rapid amplification of cDNA ends (RACE). The nucleotide sequence of the protein coding region of this cDNA shared 66-69% identity with other mammalian TNF-alpha genes. The predicted protein of 233 amino acids shared 56-58% identity with eutherian mammalian TNF-alpha was expressed in both Saccharomyces cerevisiae and Escherichia coli by constructing expression plasmid derivatives of the vectors pYES2 and pGEX-2T respectively. Cell extracts prepared from transformants and the purified GST/TNF-alpha fusion protein exhibited cytotoxic activity on the TNF-alpha-sensitive murine fibroblast L929 cells and stimulated proliferation of possum thymocyte cells. The induction of possum TNF-alpha mRNA in alveolar macrophages was analysed by RT-PCR using possum-specific TNF-alpha primers. Macrophages cultured in the presence of LPS showed enhanced transcription of TNF-alpha mRNA. This is the first report of the cloning and sequence analysis of the cDNA encoding a marsupial cytokine gene.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8724002     DOI: 10.1038/icb.1996.20

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  8 in total

1.  Modeling and simulation of the effects of cyclic loading on articular cartilage lesion formation.

Authors:  Xiayi Wang; Bruce P Ayati; Marc J Brouillete; Jason M Graham; Prem S Ramakrishnan; James A Martin
Journal:  Int J Numer Method Biomed Eng       Date:  2014-04-21       Impact factor: 2.747

2.  A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling'.

Authors:  A D Watts; N H Hunt; Y Wanigasekara; G Bloomfield; D Wallach; B D Roufogalis; G Chaudhri
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

3.  Immunome database for marsupials and monotremes.

Authors:  Emily S W Wong; Anthony T Papenfuss; Katherine Belov
Journal:  BMC Immunol       Date:  2011-08-19       Impact factor: 3.615

4.  In silico identification of opossum cytokine genes suggests the complexity of the marsupial immune system rivals that of eutherian mammals.

Authors:  Emily Sw Wong; Lauren J Young; Anthony T Papenfuss; Katherine Belov
Journal:  Immunome Res       Date:  2006-11-10

5.  A validated model of the pro- and anti-inflammatory cytokine balancing act in articular cartilage lesion formation.

Authors:  Xiayi Wang; Marc J Brouillette; Bruce P Ayati; James A Martin
Journal:  Front Bioeng Biotechnol       Date:  2015-03-10

6.  Corrigendum: "A Validated Model of the Pro- and Anti-Inflammatory Cytokine Balancing Act in Articular Cartilage Lesion Formation".

Authors:  Xiayi Wang; Marc J Brouillette; Bruce P Ayati; James A Martin
Journal:  Front Bioeng Biotechnol       Date:  2015-05-26

7.  Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters.

Authors:  Patrycja Koszałka; Ewa Szmit; Andrzej Myśliwski; Jacek Bigda
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-07-23       Impact factor: 4.291

8.  Limitations in the isolation and stimulation of splenic mononuclear cells in a dasyurid marsupial, Phascogale calura.

Authors:  C Letendre; L J Young; J M Old
Journal:  BMC Res Notes       Date:  2018-10-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.